Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hana B. Niebur"'
Autor:
Russell J. Hopp, Hana B. Niebur
Publikováno v:
Antibodies, Vol 11, Iss 2, p 30 (2022)
An elevated IgA level obtained in a 10-year-old male a year after an episode of pneumococcal sepsis led to the discovery of a broad-based IgG-specific antibody deficiency syndrome. The specifics of the case and pertinent literature are presented, inc
Externí odkaz:
https://doaj.org/article/0ed01919fd634c4da17120ced1d9df64
Autor:
Sachit Patel, Samuel J. Pirruccello, Joseph Rohr, Danita Velasco, Hana B. Niebur, Carmelita Alvares
Publikováno v:
Cytometry Part B: Clinical Cytometry. 102:415-417
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c20ad8758be23fd4880f336cbcfc065c
https://doi.org/10.1002/cyto.b.22009
https://doi.org/10.1002/cyto.b.22009
Autor:
Svetlana O. Sharapova, Christine M. Seroogy, Nurcicek Padem, Claudio Pignata, Jane Peake, Manish J. Butte, Marita Bosticardo, Anthony R. Hayward, Megan A. Cooper, Elena E. Perez, David A. Hill, Catherine M. Biggs, Nicholas L. Hartog, Jennifer Gebbia, Erwin W. Gelfand, Luigi D. Notarangelo, John W. Sleasman, Melissa E. Elder, Avinash Bhandoola, Cristina Corsino, Rosaria Prencipe, Jonathan S. Tam, Gary Kleiner, Jennifer Heimall, Lisa M. Bartnikas, Hana B. Niebur, Jennifer E. Cowan, Karin Chen, Jordan K. Abbott, Yasuhiro Yamazaki, Filiz O. Seeborg, Giuliana Giardino, Giulia Scalia, Irma Yemialyanava, Melanie A. Ruffner, Elena Crestani, Inga S. Sakovich
Publikováno v:
American journal of human genetics, vol 105, iss 3
FOXN1 is the master regulatory gene of thymic epithelium development. FOXN1 deficiency leads to thymic aplasia, alopecia, and nail dystrophy, accounting for the nude/severe combined immunodeficiency (nu/SCID) phenotype in humans and mice. We identifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b34ef7c609d2a59e804ddf499b67fb74
http://hdl.handle.net/11588/758590
http://hdl.handle.net/11588/758590
Autor:
Carla Duff, G. F. Shear, T. K. Alberdi, Hana B. Niebur, Morna J. Dorsey, John W. Sleasman, D. Nguyen
Publikováno v:
Clinical and Experimental Immunology. 181:441-450
Summary Multiple subcutaneous immunoglobulin (SCIG) products are available to treat primary antibody deficiency (PAD). The efficacy and tolerability of 16% SCIG (Vivaglobin®) was compared with 20% SCIG (Hizentra®) in PAD subjects. The study was a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec0bce8b62ada2883495da850b909738
https://doi.org/10.1111/cei.12623
https://doi.org/10.1111/cei.12623
Publikováno v:
Journal of Allergy and Clinical Immunology. 137:AB168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25dfb9e2bf73ea6b2839c01d4d0d10cb
https://doi.org/10.1016/j.jaci.2015.12.684
https://doi.org/10.1016/j.jaci.2015.12.684
Publikováno v:
Journal of Allergy and Clinical Immunology. 133:AB252
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14d2b53110c896690344eb45e5edc3f3
https://doi.org/10.1016/j.jaci.2013.12.896
https://doi.org/10.1016/j.jaci.2013.12.896